OmniAb, Inc. Common Stock

OABINASDAQ • USD
4.89 USD
↘ 0.02 (0.41%)🟢LIVE (AS OF 02:01 PM EST)
🟢Market: OPEN

Shares of OmniAb, Inc. Common Stock (OABI) are trading at $4.89. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$4.87
High?$4.89
Low?$4.77
Prev. Close?$4.91
Volume?419.9K
Avg. Volume?1.4M
VWAP?$4.84
Rel. Volume?0.30x
Bid / Ask
Bid?$4.87 × 200
Ask?$4.89 × 800
Spread?$0.02
Midpoint?$4.88
Valuation & Ratios
Market Cap?716.2M
Shares Out?145.9M
Float?88.5M
Float %?61.0%
P/E Ratio?N/A
P/B Ratio?2.87
EPS?-$0.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Employees
89
Market Cap
716.2M
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2022-11-01
Address
5980 HORTON STREET
EMERYVILLE, CA 94608
Phone: 510-250-7800
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
100
Momentum?
92
Short Sent.?
65
Piotroski F-Score?1/9Weak
Altman Z-Score?15.96Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?9.04%Elevated
Short Interest?8.0M
Days to Cover?5.2
Free Float88.5M
Avg Daily Volume1.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.21Strong
Quick Ratio?4.21Strong
Cash Ratio?1.36Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
60/100
P/E?
N/A▾
P/B?
Peers
100
S&P
58
2.87CHEAP▾
P/S?
Peers
100
S&P
3
17.81HIGH▾
P/FCF?
Peers
100
S&P
3
300.9PRICEY▾
EV/EBITDA?
S&P
97
-27.9CHEAP▾
EV/Sales?
Peers
100
S&P
3
17.24HIGH▾
Returns & Efficiency
ROE?
S&P
8
-17.5%WEAK▾
ROA?
S&P
3
-14.9%WEAK▾
Cash Flow & Enterprise
FCF?$2.4M
Enterprise Value?$693.3M
Fundamentals ratios updated end of day